Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Cancer
161-180 of 239 results
-
-
Californians Living Longer With Cancer — Some Longer Than Others
A new study from the University of California-Davis shows a significant increase in five-year survival rates for more than 20 types of cancer, but with significant disparities by race, ethnicity and economic status. That is in line with the national trend.
By Anna Gorman -
For Nursing Home Patients, Breast Cancer Surgery May Do More Harm Than Good
A new study of 6,000 older patients shows little gain from surgeries for breast cancer.
By Liz Szabo -
McCain’s Complicated Health Care Legacy: He Hated the ACA. He Also Saved It.
The six-term Arizona senator, who died Saturday, took on some of health care’s goliaths, such as the tobacco industry and insurance companies, in addition to the health law.
-
Staggering Prices Slow Insurers’ Coverage Of CAR-T Cancer Therapy
Some state Medicaid programs are not paying for the procedures, and Medicare’s complicated payment rates have hospitals concerned that it will not cover all the costs.
-
Geriatric Assessments Could Fine-Tune Cancer Care For Older Adults
The American Society of Clinical Oncology issued a new guideline that recommends adults 65 and older receive a geriatric assessment when considering or undergoing chemotherapy.
-
Must-Reads Of The Week From Brianna Labuskes
KHN’s newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don’t have to.
-
Must-Reads Of The Week From Brianna Labuskes
KHN’s newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don’t have to.
-
Listen: What You Need To Know About The News On Breast Cancer And Chemo
KHN senior correspondent Liz Szabo joins a panel on WAMU's radio show "1A" to discuss new insight into breast cancer treatment.
-
Are You And Your Primary Care Doc Ready To Talk About Your DNA?
The Pennsylvania-based health chain Geisinger plans to offer DNA sequencing as part of regular patient care.
-
Choosing Between Death And Deportation
What happens when an undocumented immigrant has a life-threatening diagnosis? Much depends on where the person lives. And even in states with generous care for a dire illness, a patient can face difficult life-and-death choices.
-
Best Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes, who reads everything on health care to compile our daily Morning Briefing, offers the best and most provocative stories for the weekend.
-
‘Rapid Autopsy’ Programs Seek Clues To Cancer Within Hours Of Death
More than a dozen centers nationwide now ask terminal patients to allow speedy study of the diseases that kill them.
-
Doctors Learn How To Talk To Patients About Dying
Clinicians can be so focused on fixing problems and saving lives that they often avoid talking to patients about their prognosis.
-
Inside The Global Race To Deliver A Vital Radioactive Isotope Used To Detect Cancer
Moly-99, as it’s called, is created in just six government-owned nuclear research reactors — none in North America — raising concerns about the reliability of the supply.
By Sarah Varney -
When You Need A Breast Screening, Should You Get A 3-D Mammogram?
The newer images are more expensive, but it’s not yet clear if they are more effective in catching cancers that will kill.
-
Doing More Harm Than Good? Epidemic of Screening Burdens Nation’s Older Patients
Patients are often aggressively screened for cancer, even if they won’t live long enough to benefit.
By Liz Szabo -
Study Gives Mixed Reviews On Laws To Equalize Cancer Patients’ Out-Of-Pocket Costs
Most states have laws that require that cancer patients who get their treatment orally rather than by infusion in a doctor’s office not pay more out-of-pocket. A new study finds that the impact of those laws is mixed.
-
California Cracks Down On Weed Killer As Lawsuits Abound
California has listed the active ingredient in Monsanto’s Roundup as a cancer-causing agent and will require warning labels on it starting next year. The company says that the listing is unjustified and that science is on its side.
-
The Painful Side Of Positive Health Care Marketing
Advertising for hospitals, unlike pharmaceutical companies, doesn't have to be backed up by data or facts. Cheerful messages of hope can feel like a slap in the face to a dying patient.